Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityOther Non-Current LiabilitiesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Cost of RevenueEBIATGross ProfitShares OutstandingShares Outstanding
Ratios

Goldenwell Biotech (GWLL) Shares Outstanding (2019 - 2025)

Goldenwell Biotech filings provide 7 years of Shares Outstanding readings, the most recent being $99.0 million for Q3 2025.

  • On a quarterly basis, Shares Outstanding rose 900.0% to $99.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $99.0 million, a 900.0% increase, with the full-year FY2024 number at $99.0 million, up 900.0% from a year prior.
  • Shares Outstanding hit $99.0 million in Q3 2025 for Goldenwell Biotech, up from $9.9 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $99.0 million in Q4 2022 to a low of $9.9 million in Q4 2023.
  • Median Shares Outstanding over the past 5 years was $96.0 million (2021), compared with a mean of $69.5 million.
  • Biggest five-year swings in Shares Outstanding: plummeted 90.0% in 2023 and later skyrocketed 900.0% in 2024.
  • Goldenwell Biotech's Shares Outstanding stood at $96.0 million in 2021, then grew by 3.12% to $99.0 million in 2022, then plummeted by 90.0% to $9.9 million in 2023, then skyrocketed by 900.0% to $99.0 million in 2024, then changed by 0.0% to $99.0 million in 2025.
  • The last three reported values for Shares Outstanding were $99.0 million (Q3 2025), $9.9 million (Q2 2025), and $9.9 million (Q1 2025) per Business Quant data.